Product Information

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE is a generic product labeled by Lannett Company Inc., priced at $0.3526 per EA under NDC 00527409537. Its NADAC has been published 350 times since Mar 4, 2020.

FDA first approved this application on Dec 17, 2019. Its Orange Book therapeutic-equivalence code is AA.

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE

Butalbital, Acetaminophen, and Caffeine Capsules
$0.3526per EA

Strength

300; 50; 40 mg/1; mg/1; mg/1

NDC

00527409537

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA212082

FDA Approved

12/17/2019

TE Code

AA

On Market Since

12/17/2019

Pharmacological Classes

Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Methylxanthine
Xanthines

Price Statistics

The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has been published 350 times since Mar 4, 2020, and over the history we have for it it has declined 78.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3526 per EA
All-time high$1.6582 (Apr 15, 2020)
All-time low$0.3110 (Apr 22, 2026)
52-week high$0.3526
52-week low$0.3110
Median price$0.5864
Average price$0.6352
Largest weekly change+34.5% (Jun 19, 2024)
Weeks tracked350
Tracking sinceMar 4, 2020

Price History

1W

0.0%

1M

+11.5%

3M

+10.2%

6M

+6.4%

1Y

+2.9%

3Y

-41.1%

5Y

-45.4%

All

-78.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Butalbital, Acetaminophen, and Caffeine Capsules market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, manufactured by Lannett Company Inc., is $0.3526 per EA (NDC 00527409537), effective Nov 11, 2026.

How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has declined 78.4%. It has been tracked across 350 weekly CMS publications since Mar 4, 2020.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

Since Mar 4, 2020, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has ranged from a low of $0.3110 (Apr 22, 2026) to a high of $1.6582 (Apr 15, 2020), with a median of $0.5864 per EA.

Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE (NDC 00527409537) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.